AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Nicotine Cessation Market Demand Analysis & Opportunity Evaluation Report 2019-2027 - ResearchAndMarkets.com

November 12, 2019 GMT

DUBLIN--(BUSINESS WIRE)--Nov 12, 2019--

The “Global Nicotine Cessation Market Demand Analysis & Opportunity Evaluation, 2019-2027” report has been added to ResearchAndMarkets.com’s offering.

The global market for nicotine cessation products was valued at USD 15.77 Billion in 2018 and is expected to grow with a CAGR of 14.37% over the forecast period (2020-2027).

On the basis of geographies, North America had the largest market share in 2018. This can be attributed to the easier availability of nicotine cessation products along with the presence of large number of market players, higher level of awareness towards the detrimental effects of nicotine consumption, and favorable reimbursement policies that encourage the utilization of effective pharmaceuticals that limit the consumption of nicotine products. The North American market is primarily driven by the US on account of easier adoption rate of innovative and popular consumer products such as electronic cigarettes.

North America market is closely followed by Europe, with a high demand from countries such as Germany, the UK, France, Italy, & Russia due to change in consumer behavior as high number of active smokers are choosing healthier lifestyles with the help of drug intervention or NRT as required along with behavioral changes such as change in diet or fitness activities that promote the nicotine cessation.

It has been observed that there is a high prevalence rate of male and female smokers in France, Germany, Italy, & the UK. Along with common respiratory disorders, smoking could also result in chronic diseases such as lung cancer or infertility in certain cases. This has resulted in a rising demand for effective products that could limit the dependence on nicotine in a minimum time.

The Asia Pacific region has been showcasing a very high demand for nicotine cessation products in the recent years. It has been observed that since countries such as China & India are presently having a very high number of active smokers and consumers of other tobacco products, and there is a high requirement for efficient resources to curb the reliance on nicotine in these countries.

Although demand for products such as electronic cigarettes are increasing rapidly, presently there is a high utilization of OTC products such as nicotine gum, lozenges, tablets, and transdermal patches. With increasing market penetration of prescription drugs that enable faster nicotine cessation, such as Zyban and Pamelor, it is expected that a high number of people would opt for these products on account of the changing socio-cultural dynamics especially in urban cities.

It has been observed that in comparison to the other regions, Latin America and Middle East & Africa have portrayed a modest growth historically. This is, however, expected to change over the forthcoming years with gradually changing consumer behavior along with rising availability of prescription drugs and various consumer products that aid in nicotine cessation.

Further it can be seen that the rising internet penetration in various developing economies is playing a crucial role in enabling the expansion of the market presence of various manufacturers and distributors, while enabling the sales of local manufacturers in reaching a wider customer base.

Key Topics Covered:

1. Executive Summary

2. Research Methodology

3. Market Dynamics

a. Driver

b. Restraints

c. Trends

d. Opportunities

4. Global Nicotine Cessation Market Outlook

5. Market Snippets by Region

a. North America

b. Europe

c. Asia Pacific

6. Government Regulations

7. Company Profile of GlaxoSmithKline

For more information about this report visit https://www.researchandmarkets.com/r/hz21oi

View source version on businesswire.com:https://www.businesswire.com/news/home/20191112005902/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: PHARMACEUTICAL HEALTH OTHER HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 11/12/2019 12:40 PM/DISC: 11/12/2019 12:40 PM

http://www.businesswire.com/news/home/20191112005902/en